![](/img/cover-not-exists.png)
A phase I study of weekly oxaliplatin (OXA) + continous infusion (CI) fluorouracil (FU) in patients with advanced colorectal cancer(CCR)
A. Aschele, S. Lonardi, L. Sartor, A. Perin, V. Chiarion Sileni, G. Artioli, S. MonfardiniVolume:
37
Year:
2001
Language:
english
DOI:
10.1016/s0959-8049(01)80757-7
File:
PDF, 192 KB
english, 2001